Systematic analysis of copy number variants of uncertain significance partially overlapping with the haploinsufficient or triplosensitive genes in clinical testing

References

• Manning M, Hudgins L, Professional P, et al. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12(11):1–7. doi: 10.1097/GIM.0b013e3181f8baad.
   PubMed Web of Science ®Google Scholar
• Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–764. doi: 10.1016/j.ajhg.2010.04.006.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol. 2013;122(6):1374–1377. doi:10.1097/01.AOG.0000438962.16108.d1
   PubMedGoogle Scholar
• Hollenbeck D, Williams CL, Drazba K, et al. Clinical relevance of small copy-number variants in chromosomal microarray clinical testing. Genet Med. 2017;19(4):377–385. doi: 10.1038/gim.2016.132.
   PubMed Web of Science ®Google Scholar
• Kearney HM, Thorland EC, Brown KK, et al. American college of medical genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–685. doi: 10.1097/GIM.0b013e3182217a3a.
   PubMed Web of Science ®Google Scholar
• Bernhardt BA, Soucier D, Hanson K, et al. Women’s experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med. 2013;15(2):139–145. doi: 10.1038/gim.2012.113.
   PubMed Web of Science ®Google Scholar
• Lou S, Lomborg K, Lewis C, et al. It’s probably nothing, but… ‘couples’ experiences of pregnancy following an uncertain prenatal genetic result. Acta Obstet Gynecol Scand. 2020;99(6):791–801. doi: 10.1111/aogs.13813.
   PubMed Web of Science ®Google Scholar
• Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American college of medical genetics and genomics (ACMG) and the clinical genome resource (ClinGen). Genet Med. 2020;22(2):245–257. doi: 10.1038/s41436-019-0686-8.
   PubMed Web of Science ®Google Scholar
• Riggs ER, Church DM, Hanson K, et al. Towards an evidence-based process for the clinical interpretation of copy number variation. Clin Genet. 2012;81(5):403–412. doi: 10.1111/j.1399-0004.2011.01818.x.
   PubMed Web of Science ®Google Scholar
• Rehm HL, Berg JS, Brooks LD, et al. –The clinical genome resource. N Engl J Med. 2015;372(23):2235–2242. doi: 10.1056/NEJMsr1406261.
   PubMed Web of Science ®Google Scholar
• Cosemans N, Vandenhove L, Vogels A, et al. The clinical relevance of intragenic NRXN1 deletions. J Med Genet. 2020;57(5):347–355. doi: 10.1136/jmedgenet-2019-106448.
   PubMed Web of Science ®Google Scholar
• Lowther C, Speevak M, Armour CM, et al. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression. Genet Med. 2017;19(1):53–61. doi: 10.1038/gim.2016.54.
   PubMed Web of Science ®Google Scholar
• Wiśniowiecka-Kowalnik B, Nesteruk M, Peters SU, et al. Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(5):983–993. doi: 10.1002/ajmg.b.31064.
   PubMed Web of Science ®Google Scholar
• Rujescu D, Ingason A, Cichon S, et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet. 2009;18(5):988–996. doi: 10.1093/hmg/ddn351.
   PubMed Web of Science ®Google Scholar
• Mansfield P, Constantino JN, Baldridge D. MYT1L: a systematic review of genetic variation encompassing schizophrenia and autism. Am J Med Genet B Neuropsychiatr Genet. 2020;183(4):227–233. doi: 10.1002/ajmg.b.32781.
   PubMed Web of Science ®Google Scholar
• Tadros S, Wang R, Waters JJ, et al. Inherited 2q23.1 microdeletions involving the MBD5 locus. Mol Genet Genomic Med. 2017;5(5):608–613. doi: 10.1002/mgg3.316.
   PubMed Web of Science ®Google Scholar
• Kushima I, Aleksic B, Nakatochi M, et al. High-resolution copy number variation analysis of schizophrenia in Japan. Mol Psychiatry. 2017;22(3):430–440. doi: 10.1038/mp.2016.88.
   PubMed Web of Science ®Google Scholar
• Mullegama SV, Rosenfeld JA, Orellana C, et al. Reciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder. Eur J Hum Genet. 2014;22(1):57–63. doi: 10.1038/ejhg.2013.67.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Chen Y, et al. Systematic analysis of copy-number variations associated with early pregnancy loss. Ultrasound Obstet Gynecol. 2020;55(1):96–104. doi: 10.1002/uog.20412.
   PubMed Web of Science ®Google Scholar
• Tsuchiya KD, Shaffer LG, Aradhya S, et al. Variability in interpreting and reporting copy number changes detected by array-based technology in clinical laboratories. Genet Med. 2009;11(12):866–873. doi: 10.1097/GIM.0b013e3181c0c3b0.
   PubMed Web of Science ®Google Scholar
• Buchanan JA, Chitayat D, Kolomietz E, et al. Prenatal genomic microarray and sequencing in Canadian medical practice: towards consensus. J Med Genet. 2015;52(9):585–586. doi: 10.1136/jmedgenet-2015-103223.
   PubMed Web of Science ®Google Scholar
• Marcou CA, Pitel B, Hagen CE, et al. Limited diagnostic impact of duplications <1 Mb of uncertain clinical significance: a 10-year retrospective analysis of reporting practices at the Mayo clinic. Genet Med. 2020;22(12):2120–2124. doi: 10.1038/s41436-020-0932-0.
   PubMed Web of Science ®Google Scholar
• Mullegama SV, Elsea SH. Intragenic MBD5 familial deletion variant does not negatively impact MBD5 mRNA expression. Mol Cytogenet. 2014;7(1):80. doi: 10.1186/s13039-014-0080-9.
   PubMedGoogle Scholar
• Yatsenko SA, Wood-Trageser M, Chu T, et al. A high-resolution X chromosome copy-number variation map in fertile females and women with primary ovarian insufficiency. Genet Med. 2019;21(10):2275–2284. doi: 10.1038/s41436-019-0505-2.
   PubMed Web of Science ®Google Scholar
• De Wel B, Willaert S, Nadaj-Pakleza A, et al. Respiratory decline in adult patients with Becker muscular dystrophy: a longitudinal study. Neuromuscul Disord. 2021;31(3):174–182. doi: 10.1016/j.nmd.2020.12.010.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Tyson C, Hrynchak M, et al. Clinical application of 2.7M cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disability. Clin Genet. 2013;83(2):145–154. doi: 10.1111/j.1399-0004.2012.01860.x.
   PubMed Web of Science ®Google Scholar
• Wein N, Vulin A, Falzarano MS, et al. Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice. Nat Med. 2014;20(9):992–1000. doi: 10.1038/nm.3628.
   PubMed Web of Science ®Google Scholar